NSI 2025: Dr. Mohana Rao Patibandla’s Groundbreaking Series On Intraventricular Brain Tumor Surgery

At NSI 2025, Dr. Mohana Rao Patibandla shared findings from India’s first large series on parafascicular intraventricular brain tumor surgery, showcasing successful outcomes and minimal complications.

Partner Content

-Oneindia Staff

NSI
2025:
Dr.
Mohana
Rao
Patibandla
Presents
India’s
First
Large
Series
on
Parafascicular
Intraventricular
Brain
Tumor
Surgery

At
the
Neurological
Society
of
India
(NSI)
2025
annual
conference,
a
presentation
from
Guntur
quietly
marked
a
potential
inflection
point
in
how
intraventricular
brain
tumors
may
be
approached
surgically
in
India.
Senior
neurosurgeon

Dr.
Mohana
Rao
Patibandla
presented
a
51-case
consecutive
series
of
parafascicular
intraventricular
tumor
resections,
making
it
the
first
and
largest
reported
Indian
experience
with
this
technique
to
date.
The
series,
spanning
both
pediatric
and
adult
patients,
examined
outcomes
using
a
minimally
invasive
parafascicular
corridor—an
approach
that
deliberately
avoids
traditional
cortical
transgression.

Why
the
Technique
Matters

Intraventricular
tumors
remain
among
the
most
technically
demanding
lesions
in
neurosurgery.
Conventional
transcortical
or
transcallosal
routes,
while
effective,
are
associated
with
risks
related
to
cortical
injury,
white
matter
disruption,
and
postoperative
neurological
deficits—particularly
in
children.
The
parafascicular
approach,
popularized
internationally
only
in
recent
years,
leverages
natural
white-matter
corridors
and
tubular
access
systems
to
minimize
approach-related
injury.
Until
now,
Indian
data
on
this
method
has
been
sparse.
The
NSI
2025
presentation
addressed
that
gap.

Key
Observations
from
the
51-Case
Series

According
to
the
data
presented:
The
series
included
tumors
of
the
lateral,
third,
and
fourth
ventricles
Both
pediatric
and
adult
patients
were
treated
using
a
standardized
minimally
invasive
strategy
High
rates
of
gross
or
near-total
resection
were
achieved
Approach-related
morbidity
was
low,
with
encouraging
functional
preservation
Blood
loss
and
operative
times
were
favorably
controlled
despite
lesion
depth
Importantly,
the
presentation
focused
not
on
novelty
alone,
but
on
reproducibility,
safety,
and
functional
outcomes,
aligning
with
contemporary
neurosurgical
priorities.
First
Adoption
in
India
While
parafascicular
intraventricular
surgery
has
been
reported
from
select
centers
internationally,
Dr.
Patibandla’s
work
represents
the
first
documented
adoption
and
sustained
use
of
this
technique
in
India,
with
the
largest
single-surgeon
dataset
currently
available.
Conference
delegates
noted
that
the
significance
of
the
series
lies
less
in
individual
achievement
and
more
in
what
it
signals:
that
advanced,
function-preserving
neurosurgical
strategies
can
be
implemented
consistently
outside
a
handful
of
global
institutions.

Academic
Rather
Than
Promotional

Unlike
many
technology-driven
presentations,
the
NSI
2025
session
maintained
a
measured
academic
tone.
The
discussion
emphasized:
Patient
selection
criteria
Learning
curve
considerations
Limitations
of
sample
size
The
need
for
longer-term
neurocognitive
outcome
data
Such
framing
positioned
the
work
as
a
foundational
Indian
dataset,
rather
than
a
definitive
endpoint.

Broader
Implications

As
neurosurgery
continues
to
move
toward
minimally
invasive,
anatomy-respecting
approaches,
indigenous
clinical
series
become
essential
for
shaping
national
guidelines,
training
paradigms,
and
patient
counseling.
The
51-case
parafascicular
intraventricular
tumor
series
presented
at
NSI
2025
may
therefore
be
remembered
less
as
a
singular
milestone
and
more
as
the
starting
reference
point
for
this
technique
in
India.

About
the
Presenter

Dr.
Mohana
Rao
Patibandla
is
a
senior
neurosurgeon
based
in
Guntur,
Andhra
Pradesh,
and
the
Founder–CMD
of
Dr.
Rao’s
Hospital.
He
has
over
two
decades
of
experience
in
brain
and
spine
surgery,
with
advanced
training
in
minimally
invasive
neurosurgery,
pediatric
neurosurgery,
skull
base
surgery,
and
functional
neurosurgery
in
India
and
the
United
States.